Semaglutide
Long-acting GLP-1 receptor agonist studied for diabetes and obesity endpoints.
Recon & Dosing
Open the calculator for Semaglutide vials.
- Category
- Metabolic / GLP-1
- Half-life
- ~7 days
- Typical vial
- 5 mg lyophilised
- Reported research dose
- 0.25–2.4 mg weekly in trial arms
Mechanism of action
Selective GLP-1 receptor agonism with albumin binding for extended half-life.
Storage & handling
Lyophilised: 2–8 °C. Reconstituted: 2–8 °C, 28 days.
Run the reconstitution math →Research notes
- The most extensively documented GLP-1 in the literature.
Research use only. Figures above summarise published literature and community protocols for reference. Nothing here is a recommendation for human use.